These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16860028)

  • 1. Effect of losartan and hydrochlorothiazide on exercise tolerance in exertional hypertension and left ventricular diastolic dysfunction.
    Little WC; Zile MR; Klein A; Appleton CP; Kitzman DW; Wesley-Farrington DJ
    Am J Cardiol; 2006 Aug; 98(3):383-5. PubMed ID: 16860028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise.
    Warner JG; Metzger DC; Kitzman DW; Wesley DJ; Little WC
    J Am Coll Cardiol; 1999 May; 33(6):1567-72. PubMed ID: 10334425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adding thiazide to a renin-angiotensin blocker improves left ventricular relaxation and improves heart failure in patients with hypertension.
    Ito H; Ishii K; Kihara H; Kasayuki N; Nakamura F; Shimada K; Fukuda S; Iwakura K; Yoshikawa J;
    Hypertens Res; 2012 Jan; 35(1):93-9. PubMed ID: 22011686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effectiveness and tolerability of losartan and effect on left ventricular mass in patients with essential hypertension].
    Tedesco MA; Ratti G; Aquino D; Caccavale A; Acitorio M; Rocereto A; Cosimi R; Coppolino P; Iarussi D; Iacono A
    Cardiologia; 1998 Jan; 43(1):53-9. PubMed ID: 9534293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of medium-dose losartan/hydrochlorothiazide and maximal-dose angiotensin II receptor blockers in the treatment of Japanese patients with uncontrolled hypertension: the Kobe-CONNECT Study.
    Toh R; Ishida T; Nishimura K; Nonaka H; Inoue Y; Kitagawa Y; Suematsu M; Miki T; Emoto N; Hirata K
    Hypertens Res; 2012 Nov; 35(11):1080-6. PubMed ID: 22786569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 52-week prospective, cohort study of the effects of losartan with or without hydrochlorothiazide (HCTZ) in hypertensive patients with metabolic syndrome.
    Racine N; Hamet P; Sampalis JS; Longo N; Bastien N
    J Hum Hypertens; 2010 Nov; 24(11):739-48. PubMed ID: 20147971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
    Ambrosioni E; Bombelli M; Cerasola G; Cipollone F; Ferri C; Grazioli I; Leprotti C; Mancia G; Melzi G; Mugellini A; Mulè G; Palasciano G; Salvetti A; Trimarco B
    Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased efficacy and tolerability with losartan plus hydrochlorothiazide in patients with uncontrolled hypertension and therapy-related symptoms receiving two monotherapies.
    Naidoo DP; Sareli P; Marin F; Aroca-Martinez G; Maritz FJ; Jardim PC; Guerrero AA; Thompson CA; Bero T; Drazka J; Kosmalova V; Dumortier T; Smith RD
    Adv Ther; 1999; 16(5):187-99. PubMed ID: 10915394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory blood pressure comparison of the anti-hypertensive efficacy of fixed combinations of irbesartan/hydrochlorothiazide and losartan/hydrochlorothiazide in patients with mild-to-moderate hypertension.
    Neutel JM; Smith D
    J Int Med Res; 2005; 33(6):620-31. PubMed ID: 16372579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of losartan plus hydrochlorothiazide on nitric oxide status in 'nondipper' hypertensive patients.
    Cammarata R; Armas-Hernández MJ; Hernández-Hernández R; Armas-Padilla MC; Sosa-Canache B; Pacheco B; Guerrero J; Israili ZH; Valasco M
    Am J Ther; 2007; 14(2):161-5. PubMed ID: 17414584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Diuretic or Calcium-Channel Blocker Plus Angiotensin-Receptor Blocker on Diastolic Function in Hypertensive Patients.
    Toh N; Ishii K; Kihara H; Iwakura K; Watanabe H; Yoshikawa J; Ito H;
    Circ J; 2016; 80(2):426-34. PubMed ID: 26725762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term antihypertensive efficacy of losartan/hydrochlorothiazide combination therapy on home blood pressure control.
    Miyagawa S; Yamada H; Matsubara H
    Clin Exp Hypertens; 2012; 34(6):439-46. PubMed ID: 22471874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.
    Calhoun DA; Lacourcière Y; Chiang YT; Glazer RD
    Hypertension; 2009 Jul; 54(1):32-9. PubMed ID: 19470877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patients.
    Okin PM; Hille DA; Kjeldsen SE; Lindholm LH; Edelman JM; Dahlöf B; Devereux RB
    Am J Hypertens; 2010 Jul; 23(7):786-93. PubMed ID: 20395941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients.
    Tedesco MA; Ratti G; Mennella S; Manzo G; Grieco M; Rainone AC; Iarussi D; Iacono A
    Am J Hypertens; 1999 Nov; 12(11 Pt 1):1130-4. PubMed ID: 10604491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Losartan reduces left ventricular hypertrophy proportionally to blood pressure reduction in hypertensives, but does not affect diastolic cardiac function.
    Zakynthinos E; Pierutsakos Ch; Konstantinidis K; Zakynthinos S; Papadogiannis D
    Angiology; 2004; 55(6):669-78. PubMed ID: 15547653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with losartan/hydrochlorothiazide for blood pressure reduction and goal attainment in a real-world clinical setting in Japan.
    Suzuki H; Shimada Y; Fujiwara K
    Ther Adv Cardiovasc Dis; 2012 Dec; 6(6):237-44. PubMed ID: 23129531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and effect on plasma B-type natriuretic peptide concentration of losartan-hydrochlorothiazide for hypertension uncontrolled by losartan-based therapy: subanalysis of a Multicentre Prospective Observational Study.
    Meno H; Inou T; Tanaka M; Tsuchiya Y; Shiga Y; Kobayashi K; Nakamura Y; Ota T; Kubara I
    Arzneimittelforschung; 2012 Sep; 62(9):414-9. PubMed ID: 22773432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.